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Abstract.  We have used an in vitro Golgi protein 
transport assay dependent on high molecular weight 
(>100 kD) cytosolic and/or peripheral  membrane pro- 
teins to study the requirements for transport from the 
cis- to the medial-compartment.  Fractionation of this 
system indicates that,  besides the NEM-sensitive fu- 
sion protein (NSF) and the soluble NSF attachment 
protein (SNAP), at least three high molecular weight 
protein fractions from bovine liver cytosol are re- 
quired.  The activity from one of these fractions was 
purified using an assay that included the second and 
third fractions in a crude state. The result is a protein 
of ll5-kD subunit molecular mass,  which we term 
pl15.  Immunodepletion of the ll5-kD protein from a 
purified preparation  with mAbs removes activity. Pep- 
tide sequence analysis of tryptic peptides indicates that 
pl15 is a "novel" protein that has not been described 
previously. Gel filtration and sedimentation analysis 
indicate that,  in its native state, pl15  is a nonglobular 
homo-oligomer, pl15 is present on purified Golgi 
membranes and can be extracted with high salt con- 
centration or alkaline pH, indicating that it is 
peripherally associated with the membrane.  Indirect 
immunofluorescence indicates that pl15 is associated 
with the Golgi apparatus  in situ. 
LUCIDATION of the mechanism by which proteins are 
transported through  the Golgi complex is of funda- 
mental importance in cell biology. In recent years, it 
has been generally agreed upon that movement involves vec- 
torial vesicular traffic  (Rothman  et al.,  1984;  Pfeffer and 
Rothman,  1987) (for a different  view see Klausner et al., 
1992;  Mellman and Simons,  1992).  That is,  vesicles bud 
from one Golgi  cisternae  (for example,  the cis-compart- 
ment), and then target to, and fuse with, the next Golgi com- 
partment (for example, the medial-compartment). This pro- 
cess  is  repeated  for  transport  from  the  medial-  to  the 
trans-cisternae.  Genetic,  biochemical,  and morphological 
analysis of these budding, targeting,  and fusion reactions has 
yielded an overall view of this process (Rothman and Orci, 
1990).  However, the details of what proteins are involved, 
and when and how they act, are poorly understood. 
One approach to studying this transport process is through 
the  use  of cell-free  systems  that  reconstitute  movement 
through the Golgi apparatus  (Balch et al.,  1984; Rothman, 
1987). These in vitro transport systems require ATP, cyto- 
solic proteins,  Golgi  membrane  proteins,  and  palmitoyl- 
coenzyme A (Fries and Rothman,  1980; Balch et al., 1984; 
Glick and Rothman,  1987; Rothman,  1987).  Several cyto- 
solic factors have been purified to homogeneity by exploiting 
the functional  cis to medial transport assay. One, N-ethyl- 
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maleimide sensitive  fusion protein (NSF), ~ acts in vesicle- 
Golgi  membrane fusion (Block et al.,  1988;  Malhotra et 
al.,  1988).  Another set,  soluble NSF attachment proteins 
(SNAPS), are required to bind NSF to the Golgi membrane 
(Weidman  et al.,  1989;  Clary et al.,  1990).  Several other 
factors have been defined by kinetic experiments or the assay 
system's susceptibility to inhibitors  Cr  et al., 1986; 
Wattenberg and Rothman,  1986; Melan~on  et al.,  1987). 
Recently, putative structural and regulatory components 
thought to be involved in vesicular traffic through the Golgi 
apparatus  have also been identified.  The most well charac- 
terized is H-COP, a component of the vesicle coat (Duden et 
al., 1991; Serafini et al., 1991b) and of the "coatomer" com- 
plex (Waters et al.,  1991). In addition,  the low molecular 
weight GTP binding protein ARF (ADP-ribosylation  factor) 
has been shown to be a Golgi protein (Stearns et al., 1990) 
associated with transport vesicles (Serafini et al., 1991a). Fi- 
nally, a ms-related small  GTP-binding  protein,  rab6p,  has 
been shown to be specifically associated with the Golgi ap- 
paratus (Goud et al., 1990) and postulated to be involved in 
the regulation  of vesicular transport (Goud and McCaffrey, 
1991). 
Information  obtained from studying the proteins involved 
in transport through the Golgi apparatus has been generally 
applicable to other vesicular traffic pathways as well. For ex- 
ample, the transport factor NSF was identified as the mare- 
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al.,  1989), a protein required for ER to Golgi transport in 
yeast (Novick et al.,  1980; Kaiser and  Schekman,  1990). 
Furthermore, a monoclonal anti-NSF antibody inhibits  ER 
to Golgi transport in semi-intact cells (Beckers et al., 1989), 
and the fusion of endocytic (Diaz  et al.,  1989) and trans- 
cytotic vesicles (E. Sztul, personal communication)  in vitro. 
Another Golgi transport protein,  ~SNAP (Clary and Roth- 
man, 1990), is related to Secl7p (Clary et al., 1990), defined 
genetically  by its involvement  in ER to Golgi transport in 
yeast (Novick et al.,  1980; Kaiser  and Schekman,  1990). 
In an attempt to further define the protein machinery in- 
volved in vesicular transport, we have modified the Golgi in- 
tercisternal  transport assay to make it dependent on high mo- 
lecular weight cytosolic and/or peripheral Golgi membrane 
proteins.  Analysis of this system indicates  that at least three 
distinct high molecular weight components are required for 
transport.  One of these factors has been purified and charac- 
terized  on the basis of this  functional  assay. 
Materials and Methods 
General Procedures 
Protein concentrations were determined with the Bio-Rad Laboratories 
(Richmond, CA) protein assay kit. All stated pH values are at room temper- 
ature. Conductivity was converted to salt concentration by using a standard 
curve of either 25 rnM TrisC1, pH 7.4,  1 mM DTT,  10% glycerol containing 
from 0 to 1 M KCI or 25 mM TrisC1, pH 7.4, 200 mM KCI, 1 mM DTT, 
10%  glycerol containing from 0 to 500 mM KPi (potassium phosphate). 
All fractionations were performed at 4~  unless otherwise indicated. Be- 
fore assaying transport activity all cytosolic fractions were dialyzed into 25 
mM TrisCl, pH 7.4, 50 mM KC1, 1 mM DTT,  10% glycerol, unless other- 
wise indicated (see Figs. 7 b and 8 b). 
Preparation of Salt Extracted Golgi Membranes 
Vesicular stomatitis virus (VSV)-G protein beating donor membranes from 
CHO 15B cells and acceptor membranes from wild-type CHO cells were 
prepared as described (Balch et al., 1984).  These membranes were subse- 
quently extracted with 1 M KCI as described (Clary and Rothman, 1990) 
except that the extraction solution contained 10 mM TrisC1,  pH 7.4, and 
the extraction was done at 0~ 
Preparation of  a Low Molecular Weight Fraction 
of Cytosol 
Cytosolic transport factors can be separated into high (Fraction 1) and low 
(Fraction 2) molecular weight pools, both of which are required for activity 
(Clary and Rothman, 1990).  A crude Fraction 2 pool was prepared as fol- 
lows: bovine brain cytosol, prepared as described (waters et al., 1991), was 
precipitated with 60%  saturated ammonium sulfate.  The pellet was re- 
suspended in 25 mM TrisC1, pH 7.4, 50 mM KC1, 1 mM DTT (at 50 rag/ 
nil), and loaded at 1 ml/min onto a 350-ml Sephacryl S-300 (Pharmacia 
Fine Chemicals, Piscataway,  NJ) column (2.6-cm inner diameter) equil- 
ibrated in the same buffer. The column was elutcd with the same buffer and 
6-ml fractions were collected. The fractions were assayed for Fraction 1 and 
Fraction 2 activity as described (Clary and Rothman, 1990).  Fractions that 
contained Fraction 2 activity but were devoid of Fraction 1 activity were 
pooled. This preparation contains cytosolic proteins that are smaller than 
r~100 kD and had a protein concentration of 5 mg/ml. 
Cis- to Medial-Golgi Transport Assay Dependent on 
High Molecular Weight Components 
The assay is a modification of that described previously by Clary and Roth- 
man (1990) with the principal changes being omission of yeast cytosol, in- 
clusion  of nucleoside  monophosphate kinase  (Waldman  and  Rudnick, 
1990),  and a KC1 concentration of 60 instead of 20 mM. The 25-/~1 assays 
contained 0.3 #Ci UDP-[aH]N-acetylglucosamine (New England Nuclear, 
Boston, MA), 5 #1 of  a 1:1 mixture of i M KCI extracted donor and acceptor 
membranes (,x,2-3/~g protein), 4/~1  (20/~g) of a pool of low molecular 
weight proteins (Fraction 2),  0.2  #1  (,u5  ng)  NSF isolated from CHO 
cytosol,  12  Izl  of various  cytosolic fractions as indicated in  the figure 
legends, an ATP and UTP regenerating system (Waldman and Rudnick, 
1990),  and palmitoyl-Coenzyme A. The final conditions, unless otherwise 
stated in the figure legends, were as follows: 25 mM Hepes-KOH, pH 7.0, 
16 mM Tris CI, pH 7.4,  60 mM KCI, 2.5 mM Mg(OAc)2,  100 #M ATE 
250/~M UTP, 5 mM creatine phosphate, 12 IU/ml creatine kinase, 10/~M 
palmitoyl-Coenzyme A, 40/~g/ml nucteotide monophosphate kinase, 200 
mM sucrose, 4.8%  (wt/vol) glycerol, and 0.64  mM DTT.  The transport 
reactions were incubated at 30~  for 2 h. [3H]N-acetylglucosamine incor- 
porated into VSV-G protein was detected by immunoprecipitation of VSV-G 
protein and scintillation counting as described (Balch et al.,  1984). 
Separation of  Bovine Brain Cytosol into 
Three Active Fractions 
350 mg of bovine brain cyt  osol (Waters et at., 1991) at 5 nag protein/ml in 25 
rnM TrisCl, pH 7.4,  100 mM KC1, 1 mM DTT was centrifuged at 10,000 g 
for 10 min to remove particulates and the material was loaded at 2 rnl/min 
onto an 8 ml Mono Q column (Pharmacia Fine Chemicals) equilibrated in 
25  mM TrisC1,  pH 7.4,  100  mM KC1,  1 mM DTT,  10%  glycerol. The 
column was washed with 10 ml of the same buffer,  and then eluted with a 
5 mM/ml KCt gradient in 25 mM TrisC1, pH 7.4,  1 mM DTT,  10% glycerol 
to 500 mM KC1, and then with a 31 mM/ml KC1 gradient to 1 M KC1.4-ml 
fractions were collected throughout, dialyzed, and assayed as described 
above. 
Preparation of  a Fraction I ~ 
1,100 mg of bovine brain c),tosol protein, prepared as described (Waters et 
al., 1991), was adjusted by addition of buffer to 5 rng protein/nil in 25 mM 
TrisCl, pH 7.4,  100 mM KC1, 1 mM DTT.  After centrifugation at %500 g 
for 10 rain to remove particulates, 160 mg of  the material (32 ml) was loaded 
at 3 ml/min onto an 8 ml Mono Q column equilibrated in 25 mM TrisC1, 
pH 7.4,  100 mM KCI, 1 mM DTT,  10% glycerol. The column was washed 
with 8 rnl of  the same buffer, and then eluted with a 40 mM/ml KCI gradient 
in 25 mM TrisC1, pH 7.4,  1 mM DTT,  10%  glycerol (i.e., from 100-320 
mM KCI in 5.5 ml), followed by a 10 mM/rrd KCI gradient in 25 mM TrisCl, 
pH 7.4,  1 mM DTT,  10% glycerol (i.e., from 320-500 mM KC1 in 18 rul). 
1 ml fractions were collected throughout. This protocol was repeated 6 more 
times, collecting the fractions in the same tubes for each run. The fractions 
were dialyzed and 6/~1 were assayed (see Fig. 4) in the presence of 6/zl 
of Fraction l'y (see Fig. 3, Fraction 37). The peak fractions were pooled 
(see Fractions 9-15,  Fig. 4) and concentrated by precipitation with 80% 
saturated ammonium sulfate in the presence of I mM EDTA. The precipi- 
tate was collected by centrifugation at 25,000 g for 20 rain, resuspended in 
10 ml of 25 mM TrisCl, pH 7.4,  1 mM DTT,  10% glycerol, and dialyzed 
against 25 ram TrisC1, pH 7.4,  50 mM KC1,  1 mM DTT,  10%  glycerol. 
This material is referred to as Fraction I~B and had a protein concentration 
of 33 mg/ml. 
Cis- to Medial-Golgi Transport Assay Dependent 
on Fraction l'y 
This assay was identical to the assay dependent on high molecular weight 
components except that the 4/~l (20 #g) of Fraction 2 pool was replaced 
with 4/~1 (130/~g) of Fraction lt~/~. This change raised the final glycerol 
concentration from 4.8 to 6.4%  (wt/vol). 
Purification of  Fraction 1",/ 
Preparation of  Bovine Liver Cytosol. Bovine liver was obtained immedi- 
ately after slaughtering, placed in ice cold 25 mM TrisC1, pH 7.4, 320 mM 
sucrose, and kept on ice till use. 450 g of tissue were placed in a glass War- 
ing blender which was then filled to the top (usually 800-810 nil) with 25 
mM TrisCl, pH 8.0, 500 mM KC1, 250 mM sucrose, 2 mM EGTA, 1 mM 
DTT, 1 mM PMSE 0.5 mM 1,10 phenanthroline, 2/~M pepstatin A, 2/~g/ml 
aprotinin, 0.5 #g/ml leupeptin (DTT and protease inhibitors were added just 
before use). The tissue was homogenized two times for 30 s separated by 
a 2-min cooling period. 
The homogenate was centrifuged at 8,500 rpm (7,500 g, k factor 3,000) 
in a Sorvall GS3 (Sorvall Instruments, Newton, CT) rotor for 1 h at 4~ 
The supernatants were decanted, pooled, and centrifuged at 39,000 rpm in 
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Inc.,  Palo Alto,  CA) for 2  h  at 4~  The supernatants were decanted, 
pooled, and dialyzed in Spectra/por 2 dialysis bags (MW cutoff 12,000- 
14,000, 6.4 ml/cm) against 30 liters of 25 mM TrisCl, pH 7.4, 50 mM KC1, 
1 mM DTT at 4~  After at least 2 h, dialysis was continued against fresh 
buffer for 4-12 h. The dialyzed material was collected and clarified by cen- 
trifugation in a Sorvall GS3 rotor at 8,500 rpm (Sorvall Instruments) for 
1 h at 4~  The supernatants were pooled. This material is termed bovine 
liver cytosol and had a protein concentration of 57 mg/ml. 
Ammonium Sulfate Precipitation. The protein concentration of the bo- 
vine liver cytosol was adjusted to 10 mg/ml by dilution with fresh dialysis 
buffer, and EDTA was added to 1 mM. The solution was transferred to a 
2 liter beaker packed in ice and solid ammonium sulfate was added slowly 
with stirring to a final concentration of 40% saturation at 0~  (added 0.229 
g/mi). After dissolution of the salt, the solution was stirred for 30 rain at 
0~  and then centrifuged in a  Sorvall GS3 rotor at 8,500 rpm for 1 h at 
4~  The supernatants were discarded and the pellets were resuspended in 
40 ml of 25 mM TrisC1, pH 7.4,  1 mM DTT,  10% glycerol with 10 strokes 
in a 40-ml Dounce homogenizer with the "B" pestle and then diluted to 
300 ml in the same buffer.  The conductivity of the solution was measured 
and then enough resuspension buffer was added so as to bring the final con- 
ductivity to the equivalent of 25 mM TrisCl, pH 7.4,  100 mM KC1, 1 mM 
DTT,  10% glycerol. Insoluble material was removed by centrifugation in 
a  Sorvall GS3  rotor at 8,500 rpm for 10 min at 4~  The resuspended, 
clarified material had a protein concentration of 6.0 mg/mi and was termed 
ammonium sulfate precipitate. 
DEAE-Cellulose  Chromatography. The clarified solution was adjusted 
to 5 mg/ml with 25 mM TrisC1, pH 7.4,  100 mM KCI, 1 mM DTT,  10% 
glycerol and was loaded at 8 ml/min onto an ,'~700-ml  DEAE-cellulose 
(Sigma Chemical Co., St. Louis, MO) column (5-cm i.d.) equilibrated in 
the same buffer. The column was washed with 300 mi of  equilibration buffer 
and then eluted with a 0.3 mM/ml KCI gradient (that is, a 1,300 ml gradient 
from 25 mM TrisCl, pH 7.4,  100 mM KC1, 1 mM DTT,  10% glycerol to 
25 mM TrisC1,  pH 7.4,  500 mM KC1, 1 mM DTT,  10% glycerol). 
The active fractions, usually from '~190-250 mM KC1, were pooled and 
termed DEAE pool. This material had a protein concentration of 1.4 mg/ml. 
Hydroxylapatite Chromatography. The KCI concentration of the DEAE 
pool was determined by measuring the conductivity, and then adjusted to 
25 mM TrisCl, pH 7.4, 200 mM KCI, 1 mM DTT,  10% glycerol by addition 
of 25 mM TrisCl, pH 7.4,  1 mM DTT,  10% glycerol. Phosphate was added 
to 10 mM by addition of 1/50 vol of 25 mM TrisCl, pH 7.4,200 mM KC1, 
1 mM DTT,  10% glycerol, 500 mM KP i. 
The solution was loaded at 1.25 ml/min onto an ,'~140 ml hydroxylapatite 
(HA Ultrogel, IBF Biotechnics, Savage,  MD) column (2.6-cm i.d.) equil- 
ibrated in 25 mM TrisCl, pH 7.4, 200 mM KC1, 1 mM DTT,  10% glycerol, 
I0 mM KPi. The column was washed with 70 ml of the same buffer and 
then eluted with a 0.5 mM/ml phosphate gradient in 25 mM TrisC1, pH 7.4, 
200 mM KC1, 1 mM DTT,  10%  glycerol. 
The active fractions, usually from '~65-110 mM KPi, were pooled and 
termed hydroxylapatite pool. This material had a protein concentration of 
0.6 mg/ml. 
Mono Q Chromatography. The hydroxylapatite pool was diluted with 25 
mM TrisC1, pH 7.4,  1 mM DTT,  10% glycerol to a conductivity equivalent 
to that of 25 mM TrisCl, pH 7.4,  150 mM KC1, 1 mM DTT,  10% glycerol 
and then centrifuged in a Sorvall GS3 rotor at 8,500 rpm for 10 min at 4~ 
The supernatant was loaded at 3 ml/min onto an 8 ml Mono Q (Pharmacia 
Fine Chemicals) column equilibrated in 25 mM TrisCl, pH 7.4,  150 mM 
KCI, 1 mM DTT,  10% glycerol. The protein was eluted with a 2.2 mM/mi 
KCI gradient in 25 mM TrisCl, pH 7.4,  1 mM DTT,  10%  glycerol. 
The active fractions, usually from ,~350-380 mM KCI, were pooled and 
termed Mono Q  pool.  This material had  a  protein concentration of 1.0 
mg/mi. 
Isoelectric Precipitation.  The Mono Q pool was transferred to Spec- 
tra/por 2 dialysis bags and dialyzed extensively against 25 mM NAMES, pH 
5.8,  1 mM DTT,  10%  glycerol at 4"C. The solution was centrifuged in a 
Sorvall SS34 rotor at 10,000 rpm (7800 g, k factor 3,000) for 15 min at 4~ 
The supernatant, which had a  protein concentration of 0.47 mg/ml, was 
aspirated. The pellets were saved for purification ofcoatomer (Waters et al., 
1991,  1992). 
S-Sepharose Cation Exchange Chromatography. The isoelectric super- 
natant was adjusted to 25 mM NAMES, pH 5.8, 25 mM NaCI, 1 mM DTT, 
10% glycerol (load buffer) by addition of 1/20th vol of 25 mM NAMES, pH 
5.8, 500 mM NaC1,  1 mM DTT,  10% glycerol. This solution was loaded 
at 0.5 mi/min onto a 6-ml S-Sepharose Fast Flow (Pharmacia Fine Chemi- 
cals) column (1-cm i.d.) equilibrated in load buffer. The column was washed 
with the same buffer and the flow-through fractions were collected and 
pooled. This material is referred to as S-Sepharose flow through and had 
a protein concentration of 0.08 mg/ml. 
Concentration  on Hydroxylapatite. The S-Sepharose flow through was 
brought to 1 mM KPi by addition of 1/1,000 vol of 1 M KPi, pH 7.4.  The 
solution was loaded onto a  1-ml hydroxylapatite (Bio-Rad HTP) column 
(0.5-cm i.d.) at 0.2 ml/min and immediately eluted (i.e., no wash step) with 
25 mM Hepes/KOH, pH 7.4,200 mM KC1, 1 mM DTT,  10% glycerol, 200 
mM KPi. 1/2-ml fractions of the eluate were collected and a protein assay 
performed. The peak fractions (usually 3-4 fractions) were pooled. 
Superose  6  Chromatography.  The  concentrated  S-Sepharose  flow- 
through was centrifuged for 10 min in a microfuge to remove any insoluble 
material and the supernatant was sieved through onto a 100-ml preparative 
grade  Superose  6  (Pharmacia  Fine  Chemicals)  column  (l.6-cm  i.d.) 
equilibrated in 25 mM Hepes/KOH, pH 7.4,  200 mM KC1, 1 mM DTT, 
10% glycerol at 0.3 ml/min. 2-ml fractions were collected and aliquots ana- 
lyzed by electrophoresis and Coomassie staining. In addition, 6.5 t~l of each 
fraction was assayed, without prior dialysis, for Fraction 13' activity.  The 
activity copurified with a homo-oligomeric complex of 115-kD subunits that 
gel filters with a Stokes radius of "~83 /~. 
Velocity Sedimentation ofp115 
pl15, after Superose 6 chromatography, was concentrated fourfold in a Cen- 
tricon 10 microconcentrator (Amicon, Beverly,  MA) and then diluted two- 
fold in the same buffer without glycerol so that the final glycerol concentra- 
tion was 5%  (wt/vol).  This solution was layered onto a  10-25%  linear 
glycerol gradient in the same buffer.  S value standards (bovine plasma ot2- 
macroglobulin, 20 S; bovine liver catalase, 11.4 S; BSA, 4.6 S) were loaded 
onto a second gradient. The gradients were centrifuged for 4.5 h in a Beck- 
man SW 55 rotor (Beckman Instruments, Inc.) at 4~  and then fractionated 
in into ,~0.43-ml fractions. 
Preparation of mAbs 
Mouse mAbs were generated according to standard techniques. Briefly, two 
8-12-wk-old BALB/C mice were immunized with 175 t~g each of purified 
p115 (through the concentration step after S-Sepharose) according to the fol- 
lowing regimen: day one, 50 #g; day 15, 50/~g; day 35, 50 #g; day 53, 25 
t~g. On day 56 spleen cells were fused to the myeloma SP2/0 cells and 
selected in hypoxanthina aminopterin thymidine (HAT) media. Primary tis- 
sue culture supernatants were screened by ELISA with 50 lag of pure p115 
per well, and an anti-mouse Ig HRP-conjugated secondary antibody for de- 
velopment with 2,2'-azinodi(3-ethyl benzthiazoline sulphonic acid).  Hy- 
bridomas that  were secreting anti-p115  antibodies were expanded.  The 
resulting tissue culture supernatants were screened for the ability to immu- 
noblot pure pl15, using an anti-mouse IgG (3' chain specific) HRP-con- 
jugated  secondary antibody for development with diaminobenzidine, to 
identify IgG secreting cell lines. Five cell lines producing antibodies that 
blotted well and recognized different minor components of  the p115 prepara- 
tion when used at high concentration (presumably proteolytic products of 
p115) were chosen for subcloning. After subcloning, tissue culture superna- 
tants were again tested by ELISA and immunoblotting and five positive 
clones (one from each line in the previous screen) were expanded and 
stored. The result is five hybridomas secreting different IgGs termed MAb- 
115-1 (an IgGl) MAbll5-2 (an IgG3),  MAbll5-3 (an IgG1), MAbll5-4 (an 
IgG2a), and MAb115-5  (an IgG0. All mAbs recognize one 115-kD protein 
in bovine liver cytosol. 
Immunoblotting 
Proteins were separated by SDS-PAGE and electroblotted onto 0.45  /~m 
nitrocellulose, which was then incubated in 5 % nonfat dry milk, PBS, 0.1 
Tween 20 (M/PBS/T). The nitrocellulose was incubated for 1 h in various 
dilutions (in  M/PBS/T)  of tissue culture  supernatants from hybridomas 
secreting anti-pll5 mAbs, washed 4 times for 5 rain each in M/PBS/T, in- 
cubated in a  1:3,000  dilution in M/PBS/T of goat anti-mouse HRP-con- 
jugated antibody (Bio-Rad Laboratories), for 1 h, and washed again. After 
washing briefly with PBS, 0.1% Tween 20, the blot was developed with the 
Amersham Corp. (Arlington Heights, IL) ECL detection kit and exposed 
to X-AR5 film (Eastman Kodak Co., Rochester, NY) in M/PBS/T. 
Immunoprecipitation of  Reductively Methylated  pll5 
Formaldehyde (1.8/~1) was added to 200/~1  of hydroxylapatite pool (0.76 
mg/ml previously dialyzed into 200 mM NaBO3,  pH 8.9). Five/~1 of 120 
mM NaB[3H]4 (5 Ci/mmole) in 0.01 N NaOH was added and incubated at 
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gel filtered through a  9-ml Sephadex G-25 (Pharmacia Fine Chemicals) 
column equilibrated in 25 mM Hepes/KOH, pH 7.4,  200 mM KCl,  10% 
glycerol to remove unincorporated sodium borohydride. The flow-through 
protein, indicated by a peak of 3H, was pooled ('01 mi). 75/~1 of this mate- 
rial was brought to 0.5% Triton X-100 and incubated for 1 h at 0*C with 
75 ~1 of tissue culture supernatant from hybridomas secreting the indicated 
antibodies. 20/~1 of a 50% suspension of Protein A-Sepharose (Pharmacia 
Fine Chemicals) in 25 mM Hepes/KOH, pH 7.4, 200 mM KC1 was added 
and mixed for  1 h  at 4~  The Sepharose was pelleted in a  microfuge, 
washed 4 times with 25 mM Hepes/KOH, pH 7.4, 200 mM KC1, 0.5% Tri- 
ton X-100, and bound protein eluted by incubation in SDS-PAGE sample 
buffer. The proteins were separated by SDS-8% PAGE, the gel was treated 
with Enlighming (New England Nuclear), and the proteins visualized by ex- 
posure to X-AR5 (Eastman Kodak and Co.). 
Preparation of  a p115-Affinity Column and 
Immunodepletion ofp115 
Cell lines MAbll5-2 and MAb115-4 were grown in protein-free hybridoma 
media (Gibco/BRL, Gaithersburg, MD).  The tissue culture supernatants 
(275 mi for MAbll5-2,100 ml for MAb115-4) were passed via gravity flow 
over a 2-ml Protein G-Sepharose Fast Flow (Pharmacia Fine Chemicals) 
column equilibrated in 25 mM TrisC1, pH 7.4, 200 mM KCI. The column 
was washed with 12 ml of  equilibration buffer, and then eluted with 100 mM 
glycine, pH 3.0. 1/2-ml fractions were collected on top of 10/~1 of 2 M "Iris 
base (to immediately neutralize the solution) and aliquots were analyzed by 
SDS-12% PAGE and Coomassie staining. The antibodies eluted in two or 
three fractions, which were pooled. We obtained 3.4 mg of MAbll5-2 and 
1.5 mg of MAblI5-4. 
Affinity columns containing a covalently coupled mixture of the two anti- 
bodies were prepared with the Pierce Immunopure Ag/Ab Immobilization 
Kit #3 as described in the manufacturers instructions (Pierce Chemical Co., 
Rockford, IL). The starting material was 3 mg of a 1:1 mixture of MAb115-2 
and MAb115-4 which yielded 2 mi of resin containing antibody covalently 
coupled via their carbohydrate moieties at an approximate concentration of 
0.5 nag of antibody/ml of resin. Two 1-ml columns were prepared with this 
resin. 
250 txl of Superose 6 purified pl15 at 60 ttg/mi in 25 mM Hepes/KOH, 
pH 7.4, 200 mM KCI, 1 mM DTT,  10% glycerol were supplemented with 
a final concentration of 125 ftg/ml soybean trypsin inhibitor (STI) (a 20-kD 
protein) so that the flow-through  could be located after passage over the anti- 
pl15 column. 200 #1 were loaded onto a 1-ml pl15 affinity column (above) 
equilibrated in the same buffer without DTT.  100 #I of equilibration buffer 
was added to the column and the antigen allowed to interact with the resin 
for 15 min, after which another 100 #1 of buffer were added followed by 
another 15-min incubation. The column was then eluted with equilibration 
buffer, 200-/xl  fractions were collected, and aliquots analyzed by  SDS- 
12.5%PAGE  and Coomassie staining.  STI  eluted predominantly in two 
fractions, which were pooled. Based on STI staining we estimate the mate- 
rial was diluted threefold by passage over the column and therefore 1 tzl of 
load and 3/~1 of flow-through are considered equivalent. There was no p115 
detected  in  the  flow-through  as  determined  by  immunoblotting  with 
MAb115-2 (the detection limit was <4 % of the concentration in the load; 
therefore, >96%  of pl15 was removed). 
Membrane Extraction ofp115 
10-/~1 aliquots of CHO Golgi (see Load in Fig. 9 c) in 10 mM TrisC1, pH 
7.4,  "030%  sucrose were extracted for 30 rain at 0*C with 20 #1 of 10 mM 
TrisC1, pH 7.4,  buffer containing 0 mM KC1, 90 mM KC1, or 1.5 M KC1 
or with 20 bd of 150 mM sodium carbonate, pH 11, giving final concentra- 
tions of 0 mM, 60 raM, and 1 M KCI, or 100 mM sodium carbonate. The 
extractions were overlaid onto 170-/~1 cushions of 20% sucrose containing 
0 mM, 60 raM, or 1 M KC1, or 100 mM sodium carbonate, pH 11, and 
centrifuged in Beckman TLA100 rotor at 50,000 rpm (100,000  g, k factor 
26) for 12 rain at 4~  (with slow acceleration and deceleration). The super- 
natants were aspirated and protein was TCA precipitated in the presence of 
deoxycholate as described (Waters et al., 1991). The pellets and precipitated 
supernatants were subjected to SDS-8% PAGE, and irnmunoblotted with 
MAb115-5. 
Immunofluorescence 
Bovine tracheal fibroblast (EBTr cells) were grown in MEM with Earle's 
balanced salt solution and 10% FCS on 12-mm glass coverslips to '~ 
confluency. All subsequent manipulations were performed at room temper- 
ature and washes were done for 5 min. The ceils were washed briefly in 
PBS/0.1% BSA (PBS/B) and then fixed in 3% paraformaldehyde in PBS for 
30 min. After three PBS/B washes, the cells were incubated in 50 t~g/mi 
wheat germ agglutinin in PBS for 30 rain, washed in PBS three times, and 
then permeabilized for 3 min in  -20~  methanol. The coverslips were 
washed two times with PBS, three times with PBS/2% BSA, and incubated 
with a  1:50 dilution of MAbll5-2 in PBS/B for 1 h.  After three PBS/B 
washes FITC-wheat germ agglutinin (Molecular Probes Inc., Eugene, OR) 
and Texas red-conjugated goat anti-mouse-IgG (Cappel Laboratories, Mal- 
vern, PA) in PBS/B was applied for 1 h. The coverslips were washed three 
times in PBS/B, twice in PBS, mounted, and viewed on a Nikon microscope 
(Nikon Inc., Melville, NY) equipped with a Bio-Rad confocal attachment. 
Results 
Development of  an Assay for High Molecular Weight 
Transport Factors 
In vitro transport of VSV-G protein from the cis- to the 
medial-compartment requires multiple eytosolic factors (Wat- 
tenberg and Rothman, 1986; Block et al., 1988;  Clary and 
Rothman, 1990).  Recently an assay was developed that uses 
Golgi membranes stripped of peripheral membrane proteins 
by extraction with high salt concentration (Clary and Roth- 
man, 1990). Transport in this system can be reconstituted by 
inclusion of whole cytosol. In addition, fractionation of  pro- 
teins into low and high molecular weight pools by gel filtra- 
tion chromatography, indicated that both small (<100 kD) 
and large (>100 kD) components were required. By assaying 
fractions of cytosol in the presence of the high molecular 
weight protein pool, three related proteins of 35, 36, and 39 
kD termed c~-, ~-,  and "y-SNAP were purified (Clary and 
Rothman, 1990).  These proteins act to bind another trans- 
port factor, NSE to the Golgi membrane before membrane 
fusion (Clary et al.,  1990). 
We have now used the converse of this assay to search for 
more transport factors. That is, we have included a low mo- 
lecular weight pool of cytosolic proteins (Fraction 2) (ClaD/ 
and Rothrnan, 1990) in our assays, which allowed us to frac- 
tionate the high molecular weight components. This assay 
also differs from the one described previously (Clary and 
Rothman, 1990) in that yeast cytosol was omitted to poten- 
tially reveal requirements for a greater array of high molecu- 
lar weight components. We found that bovine liver cytosol 
that had been precipitated with 60 % saturated ammonium 
sulfate stimulated this assay '~ a  13-fold over background 
(Fig. 1 a). Cytosol without ammonium sulfate precipitation 
stimulates the assay about 6-fold (Fig.  1 b), which is likely 
due to inhibitors in crude cytosol. Despite the lower signal 
obtained, we have used unfractionated cytosol as a starting 
material for purification of transport  factors so as not to 
overlook any high molecular weight transport components 
that may not precipitate with 60%  ammonium sulfate. 
Cis to Medial Transport Requires At Least Three High 
Molecular Weight Factors 
To determine whether we might be able to purify the high 
molecular  weight activity in  cytosol,  crude  cytosol was 
loaded on an FPLC Mono Q anion exchanger,  protein was 
eluted with a gradient of KC1 (Fig. 2 a) and fractions were 
tested for transport-stimulating activity (Fig.  2, b-d).  No 
significant  activity was detected in any fraction when assayed 
alone (Fig. 2 b), indicating that either a component was inac- 
tivated or multiple components had been separated. If yeast 
The Journal  of Cell Biology,  Volume 118,  1992  1018 Figure 1. In vitro cis- to medial-Golgi transport requires high mo- 
lecular weight cytosolic factors.  Transport from VSV-G protein 
containing CHO mutant 15B Golgi ("donor,"  lacking N-acetylglu- 
cosamine transferase 1 activity) was monitored by incorporation of 
[3H]N-acetylglucosamine into  VSV-G oligosaccharide  upon  ar- 
rival of this protein in the wild-type CHO Golgi stack ("acceptor"), 
indicated by CPMin this and the following  figures. The high molec- 
ular weight protein-dependent assay (see Materials and Methods) 
contained salt-extracted Golgi, purified CHO NSF, Fraction 2 (i.e., 
low molecular weight protein pool), an ATP and UTP regenerating 
system, palmitoyl coenzyme A and (a) either buffer or 150/~g of 
a 60%  ammonium sulfate fraction of bovine brain cytosol (see 
Materials and Methods) or (b) buffer or the indicated amount of  bo- 
vine brain cytosol that had not been ammonium sulfate precipi- 
tated. 
cytosol was included in the assay mix, small peaks of activity 
(,~1.5 times background) were detected, eluting at ~270 and 
*380 mM KC1 (data not shown). Consequently, we exam- 
ined these fractions further. Inclusion of the Mono Q frac- 
tion eluting at "~270 mM KC1 in our assays (Figs. 2, fraction 
31) gave a sharp peak of activity at ~380 mM KCI (Fig. 2 
c, fraction 37). Conversely, inclusion of the ~380 mM KC1 
fraction (Fig. 2, fraction 37), yielded a peak at *270 mM 
KC1 (Fig. 2 d, fraction 31). In addition, a small peak at ,~210 
mM KCI (Fig. 2 d, fraction 27) was consistently evident in 
multiple preparations. Since the high molecular weight cyto- 
solic pool required for transport was previously named Frac- 
tion 1, we have termed the ,~210,  ~270, and ~380 mM KC1 
peaks Fraction la,  1/~, and  1% respectively. 
Mixing experiments with the lu, 1/~, and 13, fractions indi- 
cated that all three fractions were required for optimal activ- 
ity (Fig. 3).  Since the activity can be completely reconsti- 
tuted by addition of fractions lu, 18, and 13' (Fig. 3, compare 
Cytosol and t~+/~+3'),  these fractions most likely contain all 
the high molecular weight components required for transport 
in this system. This does not mean that there are only three 
high molecular weight proteins required however, because 
some of the fractions may contain more than one activity. 
The fact that mixtures of two of the fractions (particularly, 
18 and 13,) show some transport activity may be due to con- 
tamination by the missing fraction. In fact, the magnitude of 
the signals with any two factors is consistent with the fact that 
peaks on Mono Q are often sharp on the low salt side and 
trail on the high salt side. Finally, transport in the presence 
of Fraction lo~, 18, and  13' was dependent on the presence 
of Fraction 2  and NSF (data not shown). 
Development of  an Assay for Fraction 13" 
Since our assay system was most sensitive to the presence 
of Fraction 13' (Fig. 3, compare tx/3 and ct~3") we sought to 
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Figure 2.  Transport requires multiple high molecular weight fac- 
tors. Bovine brain cytosol was fractionated (a) on FPLC Mono Q 
anion exchanger by elution with a KC1 gradient (see Materials and 
Methods) and the fractions were assayed in the high molecular 
weight protein-dependent assay (see Materials and Methods) either 
with (b) 6/~1 of each fraction alone, (c) 6/zl of the 270 mM eluate 
(fraction 31) and 6 #1 of the indicated column fraction, or (d) 6 #1 
of  the 380 mM eluate (fraction 37) and 6 #1 of the indicated column 
fraction.  Relevant KC1 concentrations are indicated in b.  Back- 
ground cpm were subtracted:  116 cpm for buffer alone in b,  183 
cpm for Fraction 31 alone in c, and 215 cpm for Fraction 37 alone 
in d. 
nent. This was done by preparation of  a fraction that contains 
both  Fraction  hx  and  18,  but  is  devoid of Fraction  13". 
Cytosol was chromatographed on Mono Q and assayed in the 
presence of Fraction 13" (Fig. 4 a). Two peaks were detected 
Waters et al. A  115-kD Golgi  Transport Factor  1019 Figure 3. Transport requires at least three high molecular weight 
factors. High molecular weight protein-dependent transport assays 
(see Materials and Methods) were performed that contained either 
buffer, 12/~1 (126/~g) of crude bovine brain cytosol (i.e., the col- 
umn load in Fig. 2), or the indicated combinations of fractions from 
the Mono Q column in Fig. 2 eluting at 210 mM KC1 (u, fraction 
27), 270 mM KCI (B, fraction 31), or 380 mM KC1 (% fraction 37), 
4 #1 each. Assays were done in duplicate. The mean is plotted, with 
the error bar representing the higher value. 
at salt concentration corresponding to the elution positions 
of Fraction 1  ot and 1/3. The region of the column encompass- 
ing the Fraction let and  1/3 peaks was pooled and termed 
Fraction 1~5.  Transport was dependent on the amount of 
Fraction lot/3 added (Fig. 4 b). In the subsequent purification 
of Fraction 13, we added 4/~1 of Fraction lab per assay. 
Unlike the case when separate lc~, I/3, and  1~/fractions 
were used (Fig. 3), transport in the presence of crude Frac- 
tion 1~/3 and Fraction 13~ was only partially dependent on 
NSF  and  independent of Fraction 2  (the  low  molecular 
weight pool, data not shown). Immunoblots of Fraction 1  c~/3 
with an anti-NSF mAb, an anti-peptide antibody that recog- 
nizes both ot- and/3-SNAP, and an anti-peptide antibody that 
recognizes ~/-SNAP indicate that Fraction 1~/3 contains both 
a- and 3,-SNAPs and high levels of NSF (data not shown). 
The presence of SNAPs is consistent with the absence of a 
requirement for Fraction 2,  while  the abundance of NSF 
(which was probably partially inactivated by the absence of 
ATP) (Block et al.,  1988) explains the partial NSF depen- 
dence. Since Fraction 2 (the low molecular weight pool) was 
no longer required in our new assay we did not include it dur- 
ing purification. Consequently our assay system consisted of 
salt-extracted Golgi membranes, NSF, Fraction lot/3 (which 
contains or  and 3,-SNAPs), and the fraction to be tested for 
Fraction 1-/activity. 
Purification of Fraction l'y 
The activity in Fraction l'y was purified from bovine liver 
cytosol by ammonium sulfate precipitation,  DEAE-cellu- 
lose anion exchange chromatography, hydroxylapatite chro- 
matography, FPLC Mono Q anion exchange chromatogra- 
phy, isoelectric precipitation, S-Sepharose cation exchange 
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Figure 4. Preparation of  a Fraction 1  ct/L 
(a) Bovine brain cytosol was fraction- 
ated on FPLC Mono Q anion exchanger 
with a steep KC1 gradient through the 
Fraction lc~ and 1/3 region followed by 
a shallow gradient through the Fraction 
13' region. 6-#1 aliquots were assayed in 
the high molecular  weight protein-de- 
pendent assay (see Materials and Meth- 
ods) in the presence of 6/zl of Fraction 
13" from the previous column (Fig. 2, 
380 mM KC1 eluate, fraction 37). Frac- 
tions 9 through 15 were pooled, termed 
Fraction limB,  and used as a complement- 
ing fraction for purification of Fraction 
13,.  (b)  Varying amounts of Fraction 
l c~/  were assayed in  the  presence  of 
6/L1 of Fraction  1~/from the previous 
column. We included 4/zl of Fraction 
lccB in assays for the purification of the 
Fraction  13" activity. 
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Percent 
Specific  activity 
Protein  activity  Purification  yield 
rag  CPM//tg  fold 
Differential centrifugation  13,000  14  [1]  [100] 
Ammonium sulfate precipitation  2,400  98  7  130 
DEAE-cellulose  290  850  61  140 
Hydroxylapatite  71.0  1,300  93  51 
Mono Q  FPLC  14.0  3,200  230  25 
Isoelectric precipitation  6,7  6,200  440  23 
S-Sepharose  1.2  15,000  1,100  10 
Superose 6 gel filtration  0.38  20,000  1,400  4 
Aliquots of the pools through the p115 purification  were dialyzed,  a twofold 
dilution series was made (down to 64-fold diluted), and 6 ~1 were assayed in 
the Fraction  17 dependent transport assay. Specific activities were estimated 
from the slope (cpm/mg protein) in the linear region of  the curves. Yields were 
corrected for sampling  during the purification. 
Figure 5. Protein profiles of fractions through the purification of 
pl15 from bovine liver. Proteins were separated by  SDS-10% 
PAGE, and visualized with Coomassie blue. Lanes contain 10 ~g 
of cytosol, ammonium sulfate precipitate, or DEAE pool, 5 tzg of 
hydroxylapatite pool, 3/~g of Mono Q pool, 2/zg of isoelectric 
precipitation supernatant or pellet, 0.8  /~g of S-Sepharose flow 
through, and 0.4 tzg of Superose 6 pool. Molecular weight markers 
(Bio-Rad) are myosin,  200 kD; ~-galactosidase, 116 kD; phosphor- 
ylase b 97 kD; BSA, 66 kD; ovalbumin, 43 kD; carbonic anhy- 
drase, 31 kD; soybean trypsin inhibitor 22 kD. 
chromatography, and gel filtration on Superose 6. We have 
described the purification from bovine liver cytosol, but the 
procedure works equally well for bovine brain cytosol. Pro- 
tein profiles of the pools  from each purification step  are 
shown in Fig. 5 and quantitation of the purification is shown 
in Table I. The increase in total activity in the early purifica- 
tion steps is presumably due to removal of components that 
interfere with the  assay.  A  typical purification results  in 
about 0.4 mg of a  115-kD protein (on SDS-PAGE)  with an 
•l,400-fold  increase in specific activity and a 4%  activity 
yield. We have termed this protein p115. 
It should be noted that dialysis of the Mono Q pool into 
pH 5.8 buffer results in precipitation of a complex of proteins 
related to the coat of Golgi transport vesicles (Waters et al., 
1991) which we have termed coatomer (Fig. 5, lsoelectric 
Precipitation Pellet). This material can be further purified as 
described (Waters  et al.,  1991, 1992). 
Amino acid sequence analysis of six tryptic peptides of 
p115  yielded  sequences  of  15-25  amino  acids  that  are 
unique, that is, they do not exhibit significant homology to 
known proteins or putative gene products. 
Preparation  of  mAb to pl15 
Purified p115 (after the S-Sepharose step) was used as an im- 
munogen in mice for production of mAbs.  Five different 
monoclonal IgGs were obtained which we term MAbll5-1, 
MAb115-2,  MAb115-3, MAbll5-4, and MAbll5-5. All rec- 
ognize a  ll5-kD  protein  on immunoblots of bovine liver 
cytosol (Fig.  6 a).  MAbll5-2,  MAbll5-3,  and MAbll5-4 
recognize native bovine protein as evidenced by their ability 
to immunoprecipitate pl15 radiolabeled by reductive meth- 
ylation (Fig. 6 b). On immunoblots of purified CHO Golgi, 
only MAbll5-5 recognizes a  ll5-kD protein (see  Fig. 9 c) 
and therefore may be the most broadly reactive mAb. 
Immunodepletion of  plI5 Removes Activity 
To demonstrate conclusively that the ll5-kD protein in our 
purified preparation was the active component, we depleted 
our pure  preparation  of pl15  by passage over an affinity 
column  that  contained  a  covalently  coupled  mixture  of 
MAbll5-2  and MAb115-4.  Soybean trypsin inhibitor was 
added to the pure pl15 as a marker of the loaded material. 
The flow-through was pooled and equivalent amounts of the 
load and flow-through (based on Coomassie staining of tryp- 
sin inhibitor) were examined. Immunoblots indicate that the 
column removed >96%  of the p115 in the load (data not 
shown).  Equivalent amounts of p115, p115 supplemented 
with  trypsin  inhibitor  (i.e.,  the  column  load),  and  the 
column flow-through were assayed for transport activity in 
the Fraction l'y dependent assay (Fig. 6 c). The purified pl 15 
was highly active and addition of soybean trypsin inhibitor 
had no effect. In contrast, the flow through had only back- 
ground activity indicating that the 115-k_D band recognized 
by the mAbs, not some minor contaminant, is responsible 
for the Fraction 13, activity. 
pl15 is a Homo-oligomer 
The final purification step of p115 uses gel filtration where 
the protein (Fig. 7 a) and corresponding activity (Fig. 7 b) 
elute with a Stokes radius of about 83 A. For a globular pro- 
tein, an 83/~ Stokes radius corresponds to ,x,700 kD. To as- 
sess whether pl15 is indeed globular we performed velocity 
sedimentation of purified p115. We found that p115, as mea- 
sured by reactivity with an anti-pll5 mAb (Fig. 8 a), and by 
activity (Fig. 8 b), has a sedimentation coefficient to about 
6.8 S, which is much lower than the expected value for a 700- 
kD globular protein. Knowing both the Stokes radius and the 
S value allowed us to estimate (Siegel and Monty, 1966) that 
Waters et al. A  l l 5-kD Golgi Transport Factor  1021 Figure 6. Anti-p115 mAbs remove Fraction 1~/activity.  (a) Immunoblot of 20 #g of bovine liver cytosol protein with different anti-p115 
mAbs. (b) Immunoprecipitation of p115 from 75 #l of radiolabeled  hydroxylapatite  pool (3H-HA pool, 7.5/~l loaded)  with the same anti- 
bodies or with buffer (no mAb). Fora and b proteins  were separated on an SDS-8% PAGE. (c) Removal ofpll5 activity by immunoaffinity 
chromatography with anti-p115 mAbs (MAb115-2,  MAb115-4).  Buffer,  120 ng (2 #1) of Supcrose 6 pure p115 (p115), 120 ng (2/zl) of 
Superose 6 pure p115 supplemented  with soybean trypsin inhibitor (p115 +  STI), or an equivalent  amount of material  (6/~1, based on 
soybean trypsin inhibitor content) after immunodepletion of p115 (ID p115 +  STI) were assayed in duplicate in the Fraction b/-dependent 
Golgi transport assay. The mean is plotted, with the error bar representing  the higher value. 
Figure Z Superose 6 gel filtra- 
tion  of  pllS.  How-through 
from the S-Sepharose column 
was concentrated and chroma- 
tographcd on an FPLC Super- 
ose 6  column (see Materials 
and  Methods).  (a)  Aliquots 
(6/zl) of fractions were sepa- 
rated by SDS-10% PAGE and 
visualized  with  Coomassie 
blue.  Molecular  size  stan- 
dards (Pharmacia Fine Chem- 
icals)  for  gel  filtration  were 
bovine  thyroid  thyroglobulin 
(669 kD, 85 Jk Stokes radius), 
horse spleen ferritin  (440 kD, 
61  ]t),  bovine  liver  catalase 
(232 kD, 52.2 ~).  Molecular 
weight  standards  for  SDS- 
PAGE were as in Fig.  5.  (b) 
Buffer,  150/~g  of a 60% am- 
monium sulfate fraction of  bo- 
vine  brain  cytosol or  6.5-#1 
aliquots  of fractions were as- 
sayed in the Fraction  l~/-de  - 
pendent assay.  The fractions 
were not dialyzed before use, 
therefore  the final  conditions 
of the  following  components 
were:  31  mM  Hepes-KOH, 
pH 7.0, 4 mM Tris C1, pH 7.4, 
4.2%  (wt/vol)  glycerol,  and 
0.42 mM DTT. 
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tion  of  pl15. Purified  pl15 
(i.e.,  after Superose 6 chro- 
matography, Fig. 7) was sedi- 
mented  through  a  glycerol 
gradient.  Fractions were col- 
lected and pl15 was detected 
by (a) SDS-8% PAGE  of 1/40 
vol of  the load and fractions, or 
the whole pellet (presumably 
a small amount of aggregated 
material), followed by immu- 
noblotting  with  MAbll5-2. 
S  value  standards  were  de- 
tected  by  Coomassie  stain- 
ing. (b) 6.5 /~1 of undialyzed 
fractions were assayed in the 
Fraction 1-/-dependent assay. 
The final conditions were as 
described  in  Materials  and 
Methods except that the final 
glycerol concentration varied 
from '~4.2-8.1%  (wt/vol). 
the native molecular mass of pl15 is '~360 kD.  These data 
suggest that p115 is a nonglobular homo-oligomer, possibly 
a trimer. 
pl15 Is a Golgi Peripheral Membrane Protein 
Since  the  assay  used  for  purification  of pl15  uses  salt- 
extracted membranes that were depleted of peripheral mem- 
brane proteins, it was possible that pl15 is either a cytosolic 
or a peripheral membrane protein. Fig. 9 a shows that when 
salt-extracted membranes are used the assay is dependent on 
added pl15. The assay plateaus at ,~400 ng pl15 (16/~g/ml, 
44 nM using 360 kD  as the molecular mass).  ~50 ng (2 
#g/ml, 6 nM) is sufficient for half-maximal stimulation. On 
a molar basis the requirement for p115 in our assay is similar 
to that for a-SNAP (~23 nM to saturate,  --5 nM at half- 
maximal stimulation) (Clary and Rothman, 1990) in a simi- 
lar assay system. In contrast to salt-extracted Golgi, when 
unextracted Golgi membranes are used there is no require- 
ment for additional pl15 (Fig. 9 b), and therefore it must be 
present on the membrane. These data indicate that pl15 is 
present on Golgi membranes and is either inactivated, or re- 
moved from the membrane by salt extraction. 
To test whether p115 is physically extracted from the mem- 
brane (as opposed to inactivated) we used a monoclonal anti- 
bovine pl15 antibody (MAbll5-5) that cross-reacts with the 
endogenous pl15 on CHO Golgi to probe supernatant and 
pellet fractions prepared under various conditions (Fig. 9 c). 
Purified CHO Golgi (Load CHO Golgi) were extracted with 
buffer alone (0 mM KCI), buffer containing 60 mM KCI, 
buffer containing 1 M KCI, or sodium carbonate, pH 11, a 
treatment known to remove peripheral membrane proteins 
(Fujiki et al.,  1982). pl15 was efficiently extracted by both 
1 M KC1 and alkali indicating it is a peripheral membrane 
protein, pl15 also dissociates from the Golgi membrane, al- 
beit less efficiently, at low salt concentration. Little p115 was 
extracted from the Golgi when 60 mM KCI was used. It is 
interesting to note that KC1 optimum of the assay used for 
purification of pl15 is 60 mM (data not shown) suggesting 
that  pl15  performs its  transport  function as  a  peripheral 
membrane protein. 
To determine where pl15  is  localized in  vivo,  we per- 
formed double-label indirect immunofluorescence with an 
anti-pll5 mAb  (MAbll5-2)  and wheat germ agglutinin in 
bovine tissue culture fibroblasts (EBTr). Fluorescent wheat 
germ agglutinin yields a distinct perinuclear crescent typical 
of Golgi localization (Fig.  10 a)  that colocalizes with the 
pl15 staining  (Fig.  10 b). 
Discussion 
We have defined a novel protein that functions in vesicular 
Waters et al. A  ll5-kD Golgi  Transport Factor  1023 Figure 9. p115 is a Golgi peripheral membrane protein. (a) Purified 
pl15 (after Superose 6 chromatography,  Fig. 7) was titrated into the 
Fraction Iv-dependent assay. (b) A 1:1 mixture of  donor and accep- 
tor membranes before salt extraction were used instead of the salt- 
extracted Golgi apparatus used in a. (c) CHO Golgi membranes 
(Load) were extracted under various conditions, separated into su- 
pernatant and pellet fractions by centrifugation, and p115 was de- 
tected by immunoblotting with an anti-bovine pl15 antibody that 
recognizes CHO pl15 (MAbll5-5). 
transport  through  the  Golgi  apparatus.  The  protein  is  a 
homo-oligomer of ll5-kD subunits and has a  nonglobular 
shape. This transport factor, which we term pl15, is a periph- 
eral membrane protein localized to the Golgi apparatus in 
vivo. In addition to pl15, we have found that transport from 
the cis- to medial-compartment is dependent on at least two 
other high molecular mass (>100 kD) factors. These compo- 
nents remain to be purified. 
Vesicular transport can be divided into discrete stages in- 
volving  budding  of transport  vesicles  from  the  "donor" 
cisternae, specific targeting of the vesicles to the next com- 
partment, and finally fusion of  the vesicle with the"acceptor" 
cisternae (Rothman and Orci,  1990).  The assay system we 
have used to identify and purify pl15 measures the overall 
transport process, and as such, defines pl15 as a functional 
component. To further refine the role of pl15 in transport, 
it would be useful to develop partial reactions that separately 
monitor the stages of budding, targeting, and fusion (Groesch 
et al.,  1990;  Rexach and Schekman,  1991). Another ap- 
proach is morphological analysis of transport reactions per- 
formed in the presence of function inhibiting anti-p115 anti- 
bodies.  None of the five monoclonal anti-pll5 antibodies 
presently available exhibit this property. 
Vesicular transport through the Golgi apparatus requires 
components that act catalytically, while other components 
are thought to play structural roles. Transport factors that 
act catalytically would be expected to be required at signifi- 
cantly lower concentrations than those that have a structural 
function. The fusion of transport vesicles with the Golgi is 
catalyzed by NSF and SNAPs (Malhotra et al., 1988; Clary 
et al., 1990).  Other components, such as coatomer (Duden 
et al., 1991; Serafini et al., 1991b; Waters et al.,  1991) and 
ARF (Stearns et al., 1990;  Donaldson et al., 1991; Serafini 
et al., 1991a), are thought to have a structural role in forma- 
tion of transport vesicles from the Golgi stack.  We have 
found that a low level of pl15 (6 nM) is required to obtain 
half-maximal transport in our assay system. This value is 
similar to that for a-SNAP (5 nM) in a similar system (Clary 
and Rothman, 1990),  suggesting that pl15 plays a catalytic 
role in the vesicular transport process. 
During the development of the pl15 purification scheme 
we discovered a complex of seven polypeptides thought to 
form the coat of Golgi transport vesicles (Malhotra et al., 
1989),  which  we  have  termed  coatomer  (Waters  et  al., 
1991). One of the coatomer polypeptides is ~-COP, which 
exhibits homology to a protein of clathrin-coated vesicles, 
termed/3-adaptin (Duden et al., 1991; Serafini et al., 1991b). 
In addition, ~-COP has been shown to rapidly dissociate 
from the  Golgi  apparatus  upon  treatment  with  the  drug 
brefeldin  A  (Donaldson  et  al.,  1990).  Since  pl15  and 
coatomer copurify through four purification steps we were 
interested in determining whether they physically interact. 
Immunoblots of column fractions from the p115 purification 
with anti-coatomer and anti-pll5 antibodies (data not shown) 
indicate that although the chromatographic behavior of p115 
and coatomer are similar, they are not identical. That is, al- 
though the peaks overlap, they are not exactly coincident, in- 
dicating that the copurification of pl15 and coatomer is not 
due to direct physical interaction. This interpretation is sup- 
ported by the absence of coatomer components in p115 im- 
munoprecipitates (Fig. 6 b). 
We anticipate that further study of p115 and the two other 
transport components we have defined will provide insight 
into the mechanism of vesicular transport through the Golgi 
apparatus and, by extension, other vesicular transport steps 
as well. 
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with  the  Golgi  complex  in 
vivo.  (a)  FITC-wheat  germ 
agglutinin and (b) MAbll5-2 
followed by a  Texas red-con- 
jugated  secondary  antibody 
were used for double-labeling 
in  a  bovine  fibroblast  line 
(EBTr). The probes colocalize 
to a perinuclear crescent, char- 
acteristic  of  Golgi  complex 
staining. No staining was evi- 
dent when the anti-p115  anti- 
body was omitted (not shown). 
Confocal imaging was done by 
Joseph Goodhouse. 
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